Profile | GDS4284 / 226757_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1448.7 | 79 |
GSM687648 | Patient 402 control | 1261.76 | 77 |
GSM687653 | Patient 403 control | 1677.11 | 82 |
GSM687658 | Patient 404 control | 6001.69 | 95 |
GSM687663 | Patient 411 control | 1213.91 | 77 |
GSM687668 | Patient 422 control | 1924.22 | 83 |
GSM687673 | Patient 424 control | 3138.26 | 89 |
GSM687678 | Patient 425 control | 2582.1 | 87 |
GSM687683 | Patient 427 control | 1642.21 | 81 |
GSM687688 | Patient 428 control | 1072.81 | 75 |
GSM687695 | Patient 441 control | 6454.09 | 95 |
GSM687699 | Patient 443 control | 1766.17 | 82 |
GSM687704 | Patient 444 control | 804.479 | 71 |
GSM687707 | Patient 448 control | 2317.54 | 86 |
GSM687712 | Patient 449 control | 1269.82 | 78 |
GSM687719 | Patient 450 control | 3052.75 | 89 |
GSM687724 | Patient 451 control | 1358.25 | 79 |
GSM687728 | Patient 452 control | 3874.6 | 91 |
GSM687646 | Patient 401 treated 24h | 1163.2 | 76 |
GSM687649 | Patient 402 treated 24h | 1544.11 | 80 |
GSM687665 | Patient 411 treated 24h | 972.41 | 73 |
GSM687651 | Patient 402 treated 4 weeks | 1127.69 | 75 |
GSM687667 | Patient 411 treated 4 weeks | 1440.9 | 79 |
GSM687670 | Patient 422 treated 24h | 1699.58 | 81 |
GSM687671 | Patient 422 treated 4 weeks | 1600.97 | 80 |
GSM687654 | Patient 403 treated 24h | 1811.07 | 83 |
GSM687675 | Patient 424 treated 24h | 2919.68 | 89 |
GSM687685 | Patient 427 treated 24h | 1308.18 | 78 |
GSM687656 | Patient 403 treated 4 weeks | 1570.78 | 80 |
GSM687677 | Patient 424 treated 4 weeks | 2242.13 | 85 |
GSM687687 | Patient 427 treated 4 weeks | 1785.39 | 82 |
GSM687692 | Patient 428 treated 4h | 1567.69 | 80 |
GSM687716 | Patient 449 treated 4h | 1292.71 | 78 |
GSM687722 | Patient 450 treated 4h | 2634.7 | 87 |
GSM687680 | Patient 425 treated 24h | 2003.71 | 84 |
GSM687690 | Patient 428 treated 24h | 1434.27 | 79 |
GSM687700 | Patient 443 treated 24h | 3522.71 | 91 |
GSM687705 | Patient 444 treated 24h | 898.812 | 73 |
GSM687714 | Patient 449 treated 24h | 1557.96 | 81 |
GSM687721 | Patient 450 treated 24h | 3984.49 | 92 |
GSM687682 | Patient 425 treated 4 weeks | 2106.72 | 84 |
GSM687694 | Patient 428 treated 4 weeks | 1091.29 | 75 |
GSM687702 | Patient 443 treated 4 weeks | 1546.23 | 80 |
GSM687718 | Patient 449 treated 4 weeks | 1565.21 | 81 |
GSM687723 | Patient 450 treated 4 weeks | 1871.71 | 83 |
GSM687661 | Patient 404 treated 4h | 5526.23 | 94 |
GSM687710 | Patient 448 treated 4h | 2113.03 | 85 |
GSM687726 | Patient 451 treated 4h | 1439.81 | 80 |
GSM687730 | Patient 452 treated 4h | 2919.3 | 90 |
GSM687660 | Patient 404 treated 24h | 22749.6 | 99 |
GSM687697 | Patient 441 treated 24h | 6495.08 | 95 |
GSM687709 | Patient 448 treated 24h | 2747.99 | 88 |
GSM687725 | Patient 451 treated 24h | 1307.2 | 78 |
GSM687729 | Patient 452 treated 24h | 4094.15 | 92 |
GSM687727 | Patient 451 treated 4 weeks | 1639.87 | 81 |
GSM687731 | Patient 452 treated 4 weeks | 12449.2 | 98 |